What is it? Case 1, 1996: Rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma

Movement Disorders

Volumn 11, Issue 3, 1996, Pages 298-310

  Fahn, Stanley ^a,f   Brin, Mitchell F ^a   Dwork, Andrew J ^b   Weiner, William J ^c   Goetz, Christopher G ^d   Rajput, Ali H ^e  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

^f NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; CHLORAMBUCIL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; HUMAN; IMPOTENCE; MALE; MULTIPLE MYELOMA; PARKINSONISM; PRIORITY JOURNAL; SIDE EFFECT; URINE INCONTINENCE; VOCALIZATION;

ANTIPARKINSON AGENTS; AUTONOMIC NERVOUS SYSTEM DISEASES; BRAIN; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMPOTENCE; LEVODOPA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEUROLOGIC EXAMINATION; PARANEOPLASTIC SYNDROMES; PARKINSON DISEASE; URINARY INCONTINENCE; VERBAL BEHAVIOR;

EID: 0029872554     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110314     Document Type: Article

References (39)

1. Fahn S, Elton RL, and members of the UPDRS Development Committee. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson's disease, vol. 2. Florham Park, NJ: Macmillan Healthcare Information, 1987: 153-163, 293-304.
2. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
3. Schwab RS, England AC Jr. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson MC, eds. Third symposium on Parkinson's disease. Edinburgh: E & S Livingstone. 1969;152-157.
4. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis of parkinsonism - a prospective study. Can J Neurol Sci 1991;18:275-278.
5. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathologic study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
6. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-148.
7. Singer C, Weiner WJ, Sanchez-Ramos JR, Ackerman M. Sexual dysfunction in men with Parkinson's disease. J Neuro Rehab 1989;3:199-204.
8. Singer C, Weiner WJ. Sexual dysfunction in Parkinson's disease. In: Singer C, Weiner WJ, eds. Sexual dysfunction: a neuro-medical approach. Armonk, NY: Futura Publishing, 1994;119-134.
9. Weiner WJ, Lang AE. Other akinetic-rigid and related syndromes. In: Movement disorders: a comprehensive survey. Mount Kisco, NY: Futura Publishing, 1989:117-219.
10. Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969;32:28-34.
11. Shulman LM, Weiner WJ. Multiple system atrophy. In: Watts RL, ed. Movement disorders: neurologic principles and practice. New York: McGraw-Hill, 1996 (in press).
12. Ito H, Ishii K, Okada K. Shirota T. Major symptoms of multiple myeloma and their management - neurologic disorders. Jpn J Clin Med 1995;53:684-689.
13. Chassande B, Leger JM. Neurological manifestations of monoclonal gammopathies. Rev Pract 1993;43:314-316.
14. Oda K, Egawa H, Okuhara T, Sakai A, Hyohdou H, Tanaka H. Kuramoto A. Meningeal involvement in Bence Jones multiple myeloma. Cancer 1991;67:1900-1902.
15. Nishiyama K, Honda E, Mizuno T, Sakuta M, Kawakami H. A case of idiopathic symmetrical non-arteriosclerotic, intracerebral calcification (Fahr's disease) associated with M-protememia, followed by multiple myeloma. Clin Neurol 1991;31:781-784.
16. Golbe LI, Miller DC, Duvoisin RC. Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism. Mov Disord 1989;4:147-152.
17. Quinn N. Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry 1989;52(Suppl):78-89.
18. Dexter DT, Carayon A, Javoy-Agid F, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991;114:1953-1975.
19. Fearnley JM, Lees AJ. Striatonigral degeneration - a clinicopathological study. Brain 1990;113:1823-1842.
20. m2 gangliosidosis: atypical spinocerebellar degeneration in a Jewish sibship. Arch Neurol 1976;33:120-130.
21. Hurowitz GI, Silver JM, Brin MF, Williams DT, Johnson WG. Neuropsychiatric aspects of adult onset Tay-Sachs disease. J Neuropsychiatry Clin Neurosci 1993;5:30-36.
22. Micheli F, Fernandez Pardal M, Giannaula R, Fahn S. Moaning in a man with Parkinsonian signs. Mov Disord 1991;6:376-378.
23. Logothetis J, Silverstein P, Coe J. Neurologic aspects of Waldenström's macroglobulinemia. Arch Neurol 1960;3: 564-573.
24. Camacho J, Arnalich F, Anciones B, et al. The spectrum of neurological manifestations in myeloma. J Med 1985;16:597-611.
25. Mueller J, Hotson JR, Langston JW. Hyper viscosity-induced dementia. Neurology 1983;33:101-103.
26. Tanaka K, Nakajima T, Atsumi T, Tanaka M, Miyatake T, Toyoshima I. Serum antibodies to brain proteins in a patient with parkinsonism associated with IgM paraproteinemia. Jpn J Med 1988;27:300-304.
27. Bajada S, Mastaglia FL, Fisher A. Amyloid neuropathy and tremor in Waldenström's macroglobulinemia. Arch Neurol 1980;37:240-242.
28. DelDuca V, Morningstar WA. Multiple myeloma associated with progressive multifocal leukoencephalopathy. JAMA 1967;199:671-673.
29. Lechner H, Berta G. Parkinsonism with a high vascular risk - Lechner-Ott syndrome. Wien Med Wochenschr 1986; 136:387-391.
30. Grufferman S, Cohen HJ, Delzell ES, Morrison MC, Schold SC Jr, Moore JO. Familial aggregation of multiple myeloma and central nervous system diseases. J Am Geriatr Soc 1989; 37:303-309.
31. Grois N, Barkovich AJ, Rosenau W, Ablis AR. Central nervous system disease associated with Langerhans cell histiocytosis. Am J Pediatr Hematol Oncol 1993;15:245-254.
32. Hasegawa K, Mitoni T, Kowa H, Motoori T, Yagisita S. A clinicopathological study of adult histiocytosis X involving the brain [review]. J Neurol Neurosurg Psychiatry 1993;56: 1006-1012.
33. Grois N, Tsunematsu Y, Bankovich AJ, Favara BE. Central nervous system disease in Langerhans cell histiocytosis. Br J Cancer 1994;23:S24-S28.
34. Breidahl WH, Ives FJ, Khaugure MS. Cerebral and brainstem Langerhans cell histiocytosis. Neuroradiology 1993;35: 349-351.
35. Montine TJ, Hollensead SC, Ellis WG, Martin JS, Moffat EJ, Burger PC. Solitary eosinophilic granuloma of the temporal lobe: a case report and long term follow up of previously reported cases. Clin Neuropathol 1994;13:225-228.
36. Rajput AH, Rozdilsky B, Rajput A, Ang L. Levodopa efficacy and pathological basis of Parkinson syndrome. Clin Neuropharmacol 1990;13:553-558.
37. Rajput AH, Pahwa R, Pahwa P, Rajput A. Prognostic significance of the onset mode in parkinsonism. Neurology 1993;43:829-830.
38. Fahn S, Greenberg J. Striatonigral degeneration. Trans Am Neurol Assoc 1972;97:275-277.
39. Friedman JH. Involuntary humming in autopsy-proven Parkinson's disease. Mov Disord 1993;8:401-402.